Login / Signup

Comprehensive lipidomics of lupus-prone mice using LC-MS/MS identifies the reduction of palmitoylethanolamide that suppresses TLR9-mediated inflammation.

Takashi OzakiNaganori KamiyamaBenjawan SaechueYasuhiro SogaRyo GotohTatsuya NakayamaChiaki FukudaAstri DewayaniThanyakorn ChalalaiShimpei ArikiSotaro OzakaAkira SonodaHaruna HiroseYoshiko GendoKaori NoguchiNozomi SachiShinya HidanoKeisuke MaeshimaKoro GotohTakayuki MasakiKoji IshiiYoshio OsadaHirotaka ShibataTakashi Kobayashi
Published in: Genes to cells : devoted to molecular & cellular mechanisms (2022)
Lipid mediators are known to play crucial roles not only in the onset of the inflammatory response but also in the induction of resolution of inflammation. Here, we report that palmitoylethanolamide (PEA), an endogenous N-acylethanolamine, can suppress the inflammation induced by Toll-like receptor (TLR) signaling both in vitro and in vivo. PEA was found to be significantly reduced in the serum and spleen of lupus-prone MRL/lpr mice analyzed by lipidomics. PEA suppressed pro-inflammatory cytokine production in a mouse macrophage cell line stimulated with TLR ligands such as lipopolysaccharide, peptidoglycan, poly (I:C), imiquimod, and CpG-ODN. PEA also inhibited both mRNA and protein levels of IL-6 in bone marrow-derived dendritic cells (BMDCs) and B cells stimulated with CpG-ODN. Augmentation of cell surface CD86 and CD40 on BMDCs and B cells, IgM production, and cell proliferation of B cells in response to CpG-ODN were attenuated by PEA. Moreover, PEA treatment significantly reduced mortality and serum IL-6 levels in mice injected with CpG-ODN plus D-galactosamine. Taken together, PEA ameliorates inflammation induced by TLR signaling, which could be a novel therapeutic target for inflammatory disorders.
Keyphrases